Lack­lus­ter da­ta on Alzheimer's drugs lead to end of Roche-AC Im­mune part­ner­ship

Roche and Genen­tech have end­ed a near­ly two-decade Alzheimer’s dis­ease part­ner­ship with Swiss biotech AC Im­mune af­ter nu­mer­ous set­backs and cloudy da­ta.

The col­lab­o­ra­tion in­volved …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER